Status:
RECRUITING
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Lead Sponsor:
Sichuan Provincial People's Hospital
Conditions:
Sepsis
Sepsis Bacterial
Eligibility:
All Genders
18-90 years
Brief Summary
This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those with bacterial sepsi...
Detailed Description
Sepsis, a major cause of morbidity and mortality in ICU patients, has garnered increased attention during the COVID-19 pandemic due to the high mortality rates associated with viral sepsis. This study...
Eligibility Criteria
Inclusion
- Patients diagnosed with sepsis according to Sepsis 3.0 criteria.
- Patients with confirmed bacterial sepsis based on positive bacterial cultures.
- Patients with confirmed viral sepsis, specifically COVID-19, diagnosed via RT-PCR for SARS-CoV-2 for viral group and negative for bacterial group.
- Patients aged 18 years and older.
- Patients admitted to the ICU during the study period.
Exclusion
- Patients with mixed bacterial and viral infections.
- Patients with sepsis not meeting the Sepsis 3.0 criteria.
- Patients who received immunomodulatory therapies other than standard treatments (e.g., investigational drugs).
- Pregnant or breastfeeding women.
Key Trial Info
Start Date :
April 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06491966
Start Date
April 2 2024
End Date
July 10 2024
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610091